The targeted knockout of the c-myc gene from rat fibroblasts leads to a stable defect in cell proliferation. We used complex cDNA libraries expressed from retroviral vectors and an efficient ...

Scientists have developed a chemical method to reverse aging in human cells without the need for genetic modification.

By tracking the changes in prostate cancer cells over time, researchers at the Johns Hopkins Kimmel Cancer Center have found that activation of the MYC gene -; a well-known cancer-causing gene ...

c-MYC is a well-validated oncogene with broad anti-cancer potential, as c-MYC expression is dysregulated in more than 70% of cancers and a key regulator in nearly every aspect of the oncogenic ...

A gene called MYC is implicated in the majority of cancers, but unfortunately it’s often considered “undruggable.” In a new study scientists have developed a molecule that chops up the RNA ...

Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer. Nature Communications, 2024; 15 (1) DOI: 10.1038/s41467-024-51450-2 ...

c-Myc plays a regular part in this protein production process—and cellular growth in general—and humans could not live without it. Occasionally, this process is disrupted.

A gene called Myc (pronounced “mick”) that is among the most important drivers of cancer in both mice and humans also plays a newly discovered crucial role in aging.

In high-grade osteosarcoma, prognostic factors at diagnosis are insufficient for stratifying patients into relevant subgroups. Recently, a transcriptomic study developed the G1/G2 gene expression ...

Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma Published Oct 24, 2024 8:00am EDT ...